FABP4 in ovarian cancer (Homo sapiens)

From WikiPathways

Revision as of 21:55, 23 October 2018 by Khanspers (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search
1LegendTumor cellHypoxiamir-409-3p mimicAggressive diseasePotential therapeutic strategiesFABP4MIR409FABP4siRNA


Description

draft

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

  1. Gharpure KM, Pradeep S, Sans M, Rupaimoole R, Ivan C, Wu SY, Bayraktar E, Nagaraja AS, Mangala LS, Zhang X, Haemmerle M, Hu W, Rodriguez-Aguayo C, McGuire M, Mak CSL, Chen X, Tran MA, Villar-Prados A, Pena GA, Kondetimmanahalli R, Nini R, Koppula P, Ram P, Liu J, Lopez-Berestein G, Baggerly K, S Eberlin L, Sood AK; ''FABP4 as a key determinant of metastatic potential of ovarian cancer.''; Nat Commun, 2018 PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
128728view02:49, 21 February 2024EweitzUpgrade disease node
128727view02:46, 21 February 2024EweitzOntology Term : 'neoplastic cell' added !
108112view10:19, 29 November 2019FehrhartOntology Term : 'cancer pathway' added !
99020view22:01, 23 October 2018KhanspersModified description
99019view21:56, 23 October 2018KhanspersOntology Term : 'microRNA pathway' added !
99018view21:56, 23 October 2018KhanspersOntology Term : 'ovarian cancer' added !
99017view21:55, 23 October 2018KhanspersNew pathway

External references

DataNodes

NameTypeDatabase referenceComment
FABP4GeneProductENSG00000170323 (Ensembl)
MIR409RnaENSG00000199107 (Ensembl)

Annotated Interactions

No annotated interactions

Retrieved from "https://classic.wikipathways.org/index.php/Pathway:WP4400"
Personal tools